当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析

上海医药

(601607)

  

流通市值:329.32亿  总市值:631.41亿
流通股本:19.32亿   总股本:37.03亿

上海医药(601607)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润49.54亿元,每股收益1.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益8014363.36万元,未分配利润3401765.09万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产21314638.04万元,负债13300274.68万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入197,508,314,193.06132,592,157,323.3766,226,461,496.33231,981,299,764.51
营业总成本191,379,813,519.61128,205,807,529.4364,033,665,635.78224,907,250,870.61
营业利润6,555,955,096.954,558,084,231.872,490,594,0099,014,650,389.27
利润总额6,518,995,175.954,533,792,505.392,491,896,591.338,808,353,281.13
净利润4,953,768,221.763,417,001,019.981,953,045,694.636,992,014,768.55
其他综合收益-170,966,425.38-122,849,260.45-31,353,262.71-226,480,312.21
综合收益总额4,782,801,796.383,294,151,759.531,921,692,431.926,765,534,456.34
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计164,628,820,577.63164,781,723,168.36157,170,379,297.84149,512,870,619.79
非流动资产合计48,517,559,819.9948,535,981,670.148,865,419,982.5948,622,030,879.16
资产总计213,146,380,397.62213,317,704,838.46206,035,799,280.43198,134,901,498.95
流动负债合计122,429,675,081.73124,339,571,550.9114,301,935,555.32110,691,046,029.78
非流动负债合计10,573,071,743.3710,035,656,400.6111,852,996,832.919,441,404,411.74
负债合计133,002,746,825.1134,375,227,951.51126,154,932,388.23120,132,450,441.52
归属于母公司股东权益合计68,509,809,654.0567,358,648,385.1368,567,457,618.3367,063,005,889.23
股东权益合计80,143,633,572.5278,942,476,886.9579,880,866,892.278,002,451,057.43
负债和股东权益合计213,146,380,397.62213,317,704,838.46206,035,799,280.43198,134,901,498.95
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计207,172,280,162.62136,202,740,273.0764,274,798,025.94252,397,143,220.13
经营活动现金流出小计204,869,819,552.94134,564,316,325.1566,898,120,438.23247,653,782,038.26
经营活动产生的现金流量净额2,302,460,609.681,638,423,947.92-2,623,322,412.294,743,361,181.87
投资活动现金流入小计25,633,471,281.913,783,614,613.69,564,308,459.6331,698,864,476.15
投资活动现金流出小计28,633,020,869.0416,398,265,181.511,670,525,926.3444,171,988,655.61
投资活动产生的现金流量净额-2,999,549,587.14-2,614,650,567.9-2,106,217,466.71-12,473,124,179.46
筹资活动现金流入小计59,457,575,645.3346,283,919,602.1226,487,446,416.7778,281,110,718.26
筹资活动现金流出小计56,661,634,536.9541,152,299,047.1822,174,397,672.8566,142,516,606.37
筹资活动产生的现金流量净额2,795,941,108.385,131,620,554.944,313,048,743.9212,138,594,111.89
汇率变动对现金及现金等价物的影响-60,841,645.22-948,933.06-12,668,704.92-12,440,028.24
现金及现金等价物净增加额2,038,010,485.74,154,445,001.9-429,159,8404,396,391,086.06
期末现金及现金等价物余额26,571,901,791.5228,688,336,307.7224,104,731,465.8224,533,891,305.82
TOP↑